标题 |
Preliminary 48-week safety and efficacy data of VIR-2218 alone and in combination with pegylated interferon alfa in participants with chronic HBV infection
VIR-2218单独用药和与聚乙二醇干扰素α联合用药在慢性HBV感染受试者中的初步48周安全性和有效性数据
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | M.-F. Yuen, Y.-S. Lim, D. Cloutier, V. Thanawala, L. Shen, S. E. Elie, et al. AASLD摘要 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |